FMRP regulates MFF translation to locally direct mitochondrial fission in neurons
Nature Cell Biology,
Journal Year:
2024,
Volume and Issue:
26(12), P. 2061 - 2074
Published: Nov. 15, 2024
Fragile
X
messenger
ribonucleoprotein
(FMRP)
is
a
critical
regulator
of
translation,
whose
dysfunction
causes
fragile
syndrome.
FMRP
disrupts
mitochondrial
health
in
neurons,
but
it
unclear
how
supports
homoeostasis.
Here
we
demonstrate
that
granules
are
recruited
to
the
midzone,
where
they
mark
fission
sites
axons
and
dendrites.
Endolysosomal
vesicles
contribute
granule
positioning
around
mitochondria
facilitate
FMRP-associated
via
Rab7
GTP
hydrolysis.
Cryo-electron
tomography
real-time
translation
imaging
reveal
mitochondria-associated
ribosome-rich
structures
serve
as
local
protein
synthesis.
Specifically,
promotes
factor
(MFF),
selectively
enabling
replicative
at
midzone.
Disrupting
function
dysregulates
MFF
perturbs
dynamics,
resulting
increased
peripheral
an
irregular
distribution
nucleoids.
Thus,
regulates
precise
control
fission.
Language: Английский
Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome
Giulia Cencelli,
No information about this author
G Pedini,
No information about this author
Claudia Ricci
No information about this author
et al.
Neurobiology of Disease,
Journal Year:
2024,
Volume and Issue:
203, P. 106726 - 106726
Published: Nov. 5, 2024
The
finely
tuned
regulation
of
mitochondria
activity
is
essential
for
proper
brain
development.
Fragile
X
Syndrome
(FXS),
the
leading
cause
inherited
intellectual
disability,
a
neurodevelopmental
disorder
in
which
mitochondrial
dysfunction
has
been
increasingly
implicated.
This
study
investigates
role
Glycogen
Synthase
Kinase
3β
(GSK3β)
FXS.
Several
studies
have
reported
dysregulation
GSK3β
FXS,
and
its
function
also
well
established.
However,
link
between
disrupted
FXS
remains
unexplored.
Utilizing
Fmr1
knockout
(KO)
mice
human
cell
lines
from
individuals
with
we
uncovered
developmental
window
where
dysregulated
disrupts
function.
Notably,
partial
inhibition
fibroblasts
young
rescues
observed
defects,
suggesting
that
targeting
early
stages
may
offer
therapeutic
benefits
this
condition.
Language: Английский